Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
6.77
+0.02 (0.30%)
Oct 7, 2026, 10:33 AM EDT - Market open
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $204.83 million as of October 7, 2026. Its market cap has decreased by -22.69% in one year.
Market Cap
204.83M
Enterprise Value
121.08M
1-Year Change
-22.69%
Ranking
Category
Stock Price
$6.77
ChartMarket Cap Chart
Since November 14, 2023, Cartesian Therapeutics's market cap has increased from $166.07M to $204.83M, an increase of 23.34%. That is a compound annual growth rate of 7.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 216.02M | 15.22% |
| Dec 31, 2025 | 187.49M | -59.31% |
| Dec 31, 2024 | 460.74M | 330.61% |
| Dec 29, 2023 | 107.00M | -35.57% |
| Nov 14, 2023 | 166.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lineage Cell Therapeutics | 234.55M |
| Keros Therapeutics | 228.41M |
| Lyell Immunopharma | 222.26M |
| Alector | 222.20M |
| Sionna Therapeutics | 219.28M |
| Compugen | 218.81M |
| Protalix BioTherapeutics | 218.35M |
| AN2 Therapeutics | 211.70M |